Research Roundup

Debbie Rigby takes a look at the latest in research news Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations Onabotulinum toxin A (BoNT-A) is approved treatment for the prevention of chronic migraine. Its efficacy increases considerably over time during long-term treatments, significantly varying among patients. Short duration of migraine,